Centre of Evidence-Based Dermatology, Queen's Medical Centre, University of Nottingham, NG7 2UH Nottingham, United Kingdom. E-mail:
Acta Derm Venereol. 2020 Jun 9;100(12):adv00166. doi: 10.2340/00015555-3516.
Despite advances in atopic dermatitis (AD) treatments, research into AD prevention has been slow. Systematic reviews of prevention strategies promoting exclusive and prolonged breastfeeding, or interventions that reduce ingested or airborne allergens during pregnancy and after birth have generally not shown convincing benefit. Maternal/infant supplements such as Vitamin D have also not shown any benefit with the possible exception of omega-3 fatty acids. Systematic reviews suggest that probiotics could reduce AD incidence by around 20%, although the studies are quite variable and might benefit from individual patient data meta-analysis. Skin barrier enhancement from birth to prevent AD and food allergy has received recent interest, and results from national trials are awaited. It is possible that trying to influence major immunological changes that characterise AD at birth through infant-directed interventions may be too late, and more attention might be directed at fetal programming in utero.
尽管特应性皮炎(AD)的治疗取得了进展,但 AD 的预防研究进展缓慢。系统评价预防策略,如促进纯母乳喂养和延长母乳喂养时间,或在妊娠和出生后减少摄入或吸入过敏原的干预措施,一般没有显示出令人信服的益处。母体/婴儿补充剂,如维生素 D,也没有显示出任何益处,除了可能的ω-3 脂肪酸。系统评价表明,益生菌可以将 AD 的发病率降低约 20%,尽管这些研究差异很大,可能受益于个体患者数据的荟萃分析。从出生开始增强皮肤屏障以预防 AD 和食物过敏最近受到关注,正在等待全国性试验的结果。通过针对婴儿的干预措施来影响出生时特应性皮炎的主要免疫变化可能为时已晚,更多的注意力可能会转向宫内胎儿编程。